ArticleFrontiers in medicine2026
Early neurological improvement as a dynamic predictor for 90-day functional outcome in acute ischemic stroke: a prospective cohort study.
Article in Frontiers in medicine, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: Early neurological improvement (ENI) within the first 24 h after acute ischemic stroke (AIS) has been proposed as a rapid dynamic predictor for treatment response. However, the prognostic value of ENI for 90-day functional recovery in real-world clinical practice remains uncertain, especially in heterogeneous stroke populations receiving mixed reperfusion treatments. We aimed to evaluate the association between 24-h neurological change and 90-day functional outcome in a contemporary single-center AIS cohort. Methods: We conducted a prospective observational cohort study including 200 consecutive AIS patients between January 2023 and December 2024. Baseline demographic, vascular risk factor, clinical, laboratory, imaging, and treatment variables were collected at admission. ENI was defined as the change in NIHSS between baseline and 24 h (ΔNIHSS = NIHSS_baseline-NIHSS_24h). Two logistic regression models were developed: Model 1, using only baseline clinical and imaging variables, and Model 2, which incorporated ΔNIHSS as a dynamic predictor. Discrimination was evaluated using the area under the receiver operating characteristic curve (AUC), and calibration was assessed using bootstrap-corrected calibration plots. Nomograms were constructed for bedside application. Results: Among 200 patients, 118 (59.0%) achieved good functional outcome at 90 days (mRS 0-2). In Model 1, age, baseline NIHSS, and ASPECTS were independently associated with 90-day outcomes, whereas hypertension was negatively associated. Model 1 demonstrated strong discrimination (AUC 0.863). While discrimination reached a prognostic plateau (AUC 0.863 vs. 0.855), the incorporation of ΔNIHSS significantly optimized model calibration, reducing the mean absolute prediction error by 47% (0.051-0.027). This indicates that the dynamic model provides substantially more accurate probability estimates for individual patients. Greater early neurological improvement was independently associated with good outcome (adjusted OR per 5-point ΔNIHSS increase, 1.48; 95% CI 1.11-1.97). Corresponding ROC curves, calibration plots, and nomograms for both models are presented. Conclusion: Early neurological improvement within 24 h after AIS serves as a reliable and rapid dynamic predictor for 90-day functional recovery. While baseline clinical and imaging variables provide strong prognostic value, incorporating early neurological change enhances model calibration and clinical usefulness. This dynamic paradigm supports integrating short-term neurological change into prognostic assessment and individualized post-stroke care.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.